We assign a fundamental rating of 2 out of 10 to SNTI. SNTI was compared to 525 industry peers in the Biotechnology industry. The financial health of SNTI is average, but there are quite some concerns on its profitability. SNTI has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

SNTI had negative earnings in the past year.
In the past year SNTI has reported a negative cash flow from operations.
SNTI had negative earnings in each of the past 5 years.
In the past 5 years SNTI always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -90.31%, SNTI is doing worse than 72.95% of the companies in the same industry.
SNTI's Return On Equity of -585.90% is on the low side compared to the rest of the industry. SNTI is outperformed by 76.19% of its industry peers.

		Industry Rank	Sector Rank
ROA	-90.31%
ROE	-585.9%
ROIC	N/A

ROA(3y)-48.54%

ROA(5y)-48.78%

ROE(3y)-85.31%

ROE(5y)-82.35%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SNTI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SNTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
SNTI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNTI has more shares outstanding
SNTI has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -12.80, we must say that SNTI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -12.80, SNTI is doing worse than 75.81% of the companies in the same industry.
SNTI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-12.8

ROIC/WACCN/A

WACC8.89%

2.3 Liquidity

SNTI has a Current Ratio of 1.51. This is a normal value and indicates that SNTI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SNTI (1.51) is worse than 81.14% of its industry peers.
SNTI has a Quick Ratio of 1.51. This is a normal value and indicates that SNTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.51, SNTI is doing worse than 80.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.51
Quick Ratio	1.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SNTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.10%, which is quite impressive.
The Revenue for SNTI has decreased by -100.00% in the past year. This is quite bad

EPS 1Y (TTM)82.1%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%89.06%

Revenue 1Y (TTM)-100%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SNTI will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.52% on average per year.
Based on estimates for the next years, SNTI will show a very strong growth in Revenue. The Revenue will grow by 73.65% on average per year.

EPS Next Y81.81%

EPS Next 2Y37.96%

EPS Next 3Y23.63%

EPS Next 5Y13.52%

Revenue Next Year-76.19%

Revenue Next 2Y-22.85%

Revenue Next 3Y-25.99%

Revenue Next 5Y73.65%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNTI. In the last year negative earnings were reported.
Also next year SNTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.